Here are the S-1 registration statements from Agape ATP Corporation (ATPC) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-1 covers the registration statement a company files to sell shares publicly, so if you follow ATPC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ATPC filings page.
Agape ATP Corporation, a Nevada holding company focused on health, wellness and emerging green energy, is conducting a firm commitment underwritten public offering of units, each consisting of one share of common stock and a five‑year warrant exercisable at 125% of the public offering price. The company will also register the common shares underlying these warrants and those issuable under a Representative’s Warrant. Net proceeds are allocated approximately 15% to sales and marketing, 40% to R&D and technology, 20% to expansion into ASEAN and US markets, 20% to vertical and horizontal integrations including M&A, with the balance for working capital and general corporate purposes.
As of March 31, 2026, Agape ATP reported current assets of $24,654,430, largely a $24,123,725 deposit with Bicheng Investment Management in China to source equity investments, where PRC foreign‑exchange rules could constrain any refund. For the three months ended March 31, 2026, revenue was $273,658 and net loss was $340,906, contributing to an accumulated deficit of $12,125,455 and management’s disclosure of substantial doubt about continuing as a going concern. The company also highlights risks related to future Nasdaq listing compliance, potential dilution from additional equity sales, and the possibility of losing part or all of the Bicheng deposit if it cannot be repatriated.
Agape ATP Corporation is planning a primary public offering of units, with each unit consisting of one share of common stock and one five-year warrant to buy an additional share. The company is also registering the shares underlying these warrants and a representative’s warrant for the underwriter.
Its stock trades on the Nasdaq Capital Market under the symbol ATPC, with a recent closing price of $4.25 per share. Agape ATP operates mainly in Malaysia, selling health and wellness products through a network marketing model, and is expanding into renewable energy and digital wellness services across ASEAN and other markets.
Net proceeds are earmarked primarily for sales and marketing, research and technological development, regional and U.S. expansion, mergers and acquisitions in health services, and general working capital. The company has recently reported operating losses and carries a significant accumulated deficit, and its filings note substantial doubt about its ability to continue as a going concern without improved cash flow and additional financing.